Figure 7.
Figure 7. Sorted CFSEbright cells after MLR have reduced ability to mediate GVHD. Purified murine CD4+ T cells were stimulated with T-cell- and NK cell-depleted MHC class II disparate splenocytes. After 8 days of culture, viable cells were analyzed. (A) MLR cultured cells were analyzed for intensity of CFSE staining; 65% of the cells were blasts, and a precursor frequency of approximately 3% was calculated. The CFSEbright gate was the sole parameter for sorting. Postsort evaluation reveals cells are markedly depleted of primed CFSEdim cells. Results were typically more than 98% purity. (B) Sorted CFSEbright T cells have much reduced GVHD-causing potential. After culture, the CFSEbright or CFSEdim cells were sorted, and 3 × 105 were transplanted. Results are from 2 pooled experiments. Mean survival times were as follows: sorted control, 20 days; CFSEdim cells, 21 days; and CFSEbright cells, more than 60 days (not reached). Comparison of CFSEbright versus sort control was very significant (P < .0003).

Sorted CFSEbright cells after MLR have reduced ability to mediate GVHD. Purified murine CD4+ T cells were stimulated with T-cell- and NK cell-depleted MHC class II disparate splenocytes. After 8 days of culture, viable cells were analyzed. (A) MLR cultured cells were analyzed for intensity of CFSE staining; 65% of the cells were blasts, and a precursor frequency of approximately 3% was calculated. The CFSEbright gate was the sole parameter for sorting. Postsort evaluation reveals cells are markedly depleted of primed CFSEdim cells. Results were typically more than 98% purity. (B) Sorted CFSEbright T cells have much reduced GVHD-causing potential. After culture, the CFSEbright or CFSEdim cells were sorted, and 3 × 105 were transplanted. Results are from 2 pooled experiments. Mean survival times were as follows: sorted control, 20 days; CFSEdim cells, 21 days; and CFSEbright cells, more than 60 days (not reached). Comparison of CFSEbright versus sort control was very significant (P < .0003).

Close Modal

or Create an Account

Close Modal
Close Modal